Comparison of Triggering Final Oocyte Maturation with Follicle Stimulating Hormone Plus Human Chorionic Gonadotropin, versus Human Chorionic Gonadotropin Alonein Normoresponder Women Undergoing Intracytoplasmic Sperm Injection: A Randomized Clinical Trial

被引:0
作者
Ansaripour, Soheila [1 ]
Tamizi, Nayereh [1 ,3 ]
Sadeghi, Mohammad Reza [2 ]
Mohammad-Akbari, Azam [1 ]
机构
[1] ACECR, Avicenna Res Inst, Nanobiotechnol Res Ctr, Tehran, Iran
[2] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran
[3] ACECR, Avicenna Res Inst, Nanobiotechnol Res Ctr, POB 1983969412, Tehran, Iran
关键词
Fertilization; Follicle Stimulating Hormone; Human Chorionic Gonadotropin; Pregnancy Rate; Triggering Oocyte Maturation; IN-VITRO FERTILIZATION; GNRH AGONIST; DUAL TRIGGER; HCG; COMBINATION; IMPROVES; CYCLES; TIME;
D O I
10.22074/IJFS.2021.532258.1141
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Few studies have so far been done about the role of follicle stimulating hormone (FSH) in final oocyte maturation. However, none of these studies have been performed solely on normoresponder patients. This study aimed to determine whether oocyte maturation, as well as fertilization and pregnancy rates, could be improved in normore-sponder women with concomitant FSH and human chorionic gonadotropin (hCG) trigger compared to those with the hCG trigger alone.Materials and Methods: In this prospective randomized clinical trial, 117 normoresponder women, aged 19-40 years who were candidates for the gonadotropin-releasing hormone (GnRH) antagonist protocol at Avicenna Infertility treatment Center, were enrolled and claasified in two groups. Final oocyte maturation was triggered using 10000 IU of hCG plus 450 IU of FSH in the first group (59 subjects) and 10000 IU of hCG alone in the second group (58 subjects). The primary outcome was clinical pregnancy rate.Results: Mean age of the patients was 33.21 +/- 4.41 years. There was no difference in clinical pregnancy among the two groups (30.9% vs. 25.5%, P=0.525). There was no statistically significant difference in fertilization rate (80.0% vs. 74.1%, P=0.106), implantation rates (18.9% vs. 16.7%, P=0.352), and chemical pregnancy rates (38.2% vs. 32.7%, P=0.550). Oocyte maturation rate (84.2% vs. 73.6%, P<0.001), 2 pronuclei (2PNs) (6.53 +/- 2.54 vs. 5.36 +/- 2.85, P=0.021) and total embryos (5.85 +/- 2.43 vs. 4.91 +/- 2.58, P=0.046) were significantly higher in the first group.Conclusion: Adding FSH to hCG for oocyte triggering, significantly improved oocyte maturation rates and total em-bryos. While there was no significant difference in the clinical and chemical pregnancy rates, between these two groups (registration number: IRCT20190108042285N1).
引用
收藏
页码:162 / 166
页数:5
相关论文
共 19 条
[1]   Criteria for number of embryos to transfer: a committee opinion [J].
不详 .
FERTILITY AND STERILITY, 2013, 99 (01) :44-46
[2]  
Anaya Y, 2018, J ASSIST REPROD GEN, V35, P297, DOI 10.1007/s10815-017-1074-4
[3]   Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction [J].
Andersen, C. Yding ;
Humaidan, P. ;
Ejdrup, H. Bredkjaer ;
Bungum, L. ;
Grondahl, M. L. ;
Westergaard, L. G. .
HUMAN REPRODUCTION, 2006, 21 (08) :2126-2130
[4]   Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program [J].
Bianchi, Veronica ;
Dal Prato, Luca ;
Maccolini, Andrea ;
Mazzone, Silvia ;
Borini, Andrea .
FERTILITY AND STERILITY, 2009, 92 (05) :1747.e1-1747.e3
[5]   Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis [J].
Chen, Chi-Huang ;
Tzeng, Chii-Ruey ;
Wang, Peng-Hui ;
Liu, Wei-Min ;
Chang, Heng-Yu ;
Chen, Huang-Hui ;
Chen, Ching-Hui .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (01) :17-26
[6]   Comparison of Oocyte Maturation Trigger Using Follicle Stimulating Hormone Plus Human Chorionic Gonadotropin versus hCG Alone in Assisted Reproduction Technology Cycles [J].
Dashti, Saeedeh ;
Aflatoonian, Abbas ;
Tabibnejad, Nasim .
INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2019, 13 (02) :102-107
[7]   Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis [J].
Ding, Nan ;
Liu, Xingchen ;
Jian, Qihang ;
Liang, Zhonghen ;
Wang, Fang .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 218 :92-98
[8]   GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study [J].
Engmann, L ;
Benadiva, C .
HUMAN REPRODUCTION, 2005, 20 (11) :3258-3260
[9]  
ESHRE Special Interest Grp, 2017, HUM REPROD OPEN, V2017, DOI [10.1016/j.rbmo.2017.06.015, 10.1093/hropen/hox011]
[10]   1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study [J].
Humaidan, Peter ;
Bredkjaer, Helle Ejdrup ;
Westergaard, Lars Grabou ;
Andersen, Claus Yding .
FERTILITY AND STERILITY, 2010, 93 (03) :847-854